Interleukin‐17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma

The programmed cell death 1/programmed cell death 1 ligand 1 pathway was successfully targeted in cancer immunotherapy. Elevated interleukin‐17 (IL‐17), which is known in autoimmune diseases, has recently been recognized in cancer patients. We investigated the role of IL‐17 in the regulation of expr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Sci
Autori principali: Aotsuka, Aeri, Matsumoto, Yoko, Arimoto, Takahide, Kawata, Akira, Ogishima, Juri, Taguchi, Ayumi, Tanikawa, Michihiro, Sone, Kenbun, Mori‐Uchino, Mayuyo, Tsuruga, Tetsushi, Oda, Katsutoshi, Kawana, Kei, Osuga, Yutaka, Fujii, Tomoyuki
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6778630/
https://ncbi.nlm.nih.gov/pubmed/31432577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14174
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi